Monural (Fosfomycin Trometamol)

Fosfomycin trometamol inhibits the bacterial MurA enzyme, which catalyzes the first step of peptidoglycan synthesis. By blocking this enzyme, the drug prevents formation of the bacterial cell wall, leading to osmotic instability, cell lysis, and death of susceptible bacteria.

The prescribed dose of Monural is determined by the treating physician based on local guidelines and patient characteristics. In most regions a single oral dose is recommended for uncomplicated cystitis, but the exact amount and any adjustments must follow the prescriber's order.

Safety data for fosfomycin trometamol in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Monural, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Monural offers a single‑dose oral regimen, which can improve adherence compared with multi‑day courses such as nitrofurantoin or trimethoprim‑sulfamethoxazole. Its spectrum includes many common uropathogens, but local resistance patterns should guide selection, as some strains may be resistant to fosfomycin while remaining susceptible to other agents.

Monural should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Monural is taken orally, usually with a full glass of water. It is often recommended to be taken on an empty stomach (at least 2 hours before or after a meal) to maximize absorption, unless the prescribing information advises otherwise.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, skin disorders like Stevens‑Johnson syndrome, and Clostridioides difficile‑associated colitis. Patients should be instructed to seek immediate medical attention if they develop rash, swelling, difficulty breathing, or persistent diarrhea.

Monural is contraindicated in individuals with a known hypersensitivity to fosfomycin trometamol or any component of the formulation. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those with a history of severe allergic reactions to other antibiotics.